Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure
• Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomo...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Pasalic, Dario [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells - Han, Xiaobing ELSEVIER, 2021, journal of the European Society for Therapeutic Radiology and Oncology, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:145 ; year:2020 ; pages:178-185 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.radonc.2020.01.010 |
|---|
| Katalog-ID: |
ELV050049801 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV050049801 | ||
| 003 | DE-627 | ||
| 005 | 20230624161606.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200518s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.radonc.2020.01.010 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica |
| 035 | |a (DE-627)ELV050049801 | ||
| 035 | |a (ELSEVIER)S0167-8140(20)30022-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 540 |q VZ |
| 100 | 1 | |a Pasalic, Dario |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure |
| 264 | 1 | |c 2020 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. | ||
| 650 | 7 | |a Stereotactic body radiotherapy |2 Elsevier | |
| 650 | 7 | |a Pulmonary oligometastases |2 Elsevier | |
| 650 | 7 | |a Nomogram |2 Elsevier | |
| 650 | 7 | |a Oligometastasis |2 Elsevier | |
| 650 | 7 | |a Intrathoracic control |2 Elsevier | |
| 700 | 1 | |a Lu, Yi |4 oth | |
| 700 | 1 | |a Betancourt-Cuellar, Sonia L. |4 oth | |
| 700 | 1 | |a Taku, Nicolette |4 oth | |
| 700 | 1 | |a Mesko, Shane M. |4 oth | |
| 700 | 1 | |a Bagley, Alexander F. |4 oth | |
| 700 | 1 | |a Chance, William W. |4 oth | |
| 700 | 1 | |a Allen, Pamela K. |4 oth | |
| 700 | 1 | |a Tang, Chad |4 oth | |
| 700 | 1 | |a Antonoff, Mara B. |4 oth | |
| 700 | 1 | |a Balter, Peter A. |4 oth | |
| 700 | 1 | |a Mehran, Reza J. |4 oth | |
| 700 | 1 | |a Welsh, James W. |4 oth | |
| 700 | 1 | |a Liao, Zhongxing |4 oth | |
| 700 | 1 | |a Gomez, Daniel |4 oth | |
| 700 | 1 | |a Erasmus, Jeremy J. |4 oth | |
| 700 | 1 | |a Nguyen, Quynh-Nhu |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Han, Xiaobing ELSEVIER |t Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |d 2021 |d journal of the European Society for Therapeutic Radiology and Oncology |g Amsterdam [u.a.] |w (DE-627)ELV00004122X |
| 773 | 1 | 8 | |g volume:145 |g year:2020 |g pages:178-185 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.radonc.2020.01.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 145 |j 2020 |h 178-185 |g 8 | ||
| author_variant |
d p dp |
|---|---|
| matchkey_str |
pasalicdarioluyibetancourtcuellarsonialt:2020----:troatcbaieaitoteayoploayeatssmrvnoealuvvlnietfig |
| hierarchy_sort_str |
2020 |
| publishDate |
2020 |
| allfields |
10.1016/j.radonc.2020.01.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica (DE-627)ELV050049801 (ELSEVIER)S0167-8140(20)30022-0 DE-627 ger DE-627 rakwb eng 570 540 VZ Pasalic, Dario verfasserin aut Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure 2020 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Elsevier Lu, Yi oth Betancourt-Cuellar, Sonia L. oth Taku, Nicolette oth Mesko, Shane M. oth Bagley, Alexander F. oth Chance, William W. oth Allen, Pamela K. oth Tang, Chad oth Antonoff, Mara B. oth Balter, Peter A. oth Mehran, Reza J. oth Welsh, James W. oth Liao, Zhongxing oth Gomez, Daniel oth Erasmus, Jeremy J. oth Nguyen, Quynh-Nhu oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:145 year:2020 pages:178-185 extent:8 https://doi.org/10.1016/j.radonc.2020.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 145 2020 178-185 8 |
| spelling |
10.1016/j.radonc.2020.01.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica (DE-627)ELV050049801 (ELSEVIER)S0167-8140(20)30022-0 DE-627 ger DE-627 rakwb eng 570 540 VZ Pasalic, Dario verfasserin aut Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure 2020 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Elsevier Lu, Yi oth Betancourt-Cuellar, Sonia L. oth Taku, Nicolette oth Mesko, Shane M. oth Bagley, Alexander F. oth Chance, William W. oth Allen, Pamela K. oth Tang, Chad oth Antonoff, Mara B. oth Balter, Peter A. oth Mehran, Reza J. oth Welsh, James W. oth Liao, Zhongxing oth Gomez, Daniel oth Erasmus, Jeremy J. oth Nguyen, Quynh-Nhu oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:145 year:2020 pages:178-185 extent:8 https://doi.org/10.1016/j.radonc.2020.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 145 2020 178-185 8 |
| allfields_unstemmed |
10.1016/j.radonc.2020.01.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica (DE-627)ELV050049801 (ELSEVIER)S0167-8140(20)30022-0 DE-627 ger DE-627 rakwb eng 570 540 VZ Pasalic, Dario verfasserin aut Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure 2020 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Elsevier Lu, Yi oth Betancourt-Cuellar, Sonia L. oth Taku, Nicolette oth Mesko, Shane M. oth Bagley, Alexander F. oth Chance, William W. oth Allen, Pamela K. oth Tang, Chad oth Antonoff, Mara B. oth Balter, Peter A. oth Mehran, Reza J. oth Welsh, James W. oth Liao, Zhongxing oth Gomez, Daniel oth Erasmus, Jeremy J. oth Nguyen, Quynh-Nhu oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:145 year:2020 pages:178-185 extent:8 https://doi.org/10.1016/j.radonc.2020.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 145 2020 178-185 8 |
| allfieldsGer |
10.1016/j.radonc.2020.01.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica (DE-627)ELV050049801 (ELSEVIER)S0167-8140(20)30022-0 DE-627 ger DE-627 rakwb eng 570 540 VZ Pasalic, Dario verfasserin aut Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure 2020 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Elsevier Lu, Yi oth Betancourt-Cuellar, Sonia L. oth Taku, Nicolette oth Mesko, Shane M. oth Bagley, Alexander F. oth Chance, William W. oth Allen, Pamela K. oth Tang, Chad oth Antonoff, Mara B. oth Balter, Peter A. oth Mehran, Reza J. oth Welsh, James W. oth Liao, Zhongxing oth Gomez, Daniel oth Erasmus, Jeremy J. oth Nguyen, Quynh-Nhu oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:145 year:2020 pages:178-185 extent:8 https://doi.org/10.1016/j.radonc.2020.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 145 2020 178-185 8 |
| allfieldsSound |
10.1016/j.radonc.2020.01.010 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica (DE-627)ELV050049801 (ELSEVIER)S0167-8140(20)30022-0 DE-627 ger DE-627 rakwb eng 570 540 VZ Pasalic, Dario verfasserin aut Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure 2020 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Elsevier Lu, Yi oth Betancourt-Cuellar, Sonia L. oth Taku, Nicolette oth Mesko, Shane M. oth Bagley, Alexander F. oth Chance, William W. oth Allen, Pamela K. oth Tang, Chad oth Antonoff, Mara B. oth Balter, Peter A. oth Mehran, Reza J. oth Welsh, James W. oth Liao, Zhongxing oth Gomez, Daniel oth Erasmus, Jeremy J. oth Nguyen, Quynh-Nhu oth Enthalten in Elsevier Science Han, Xiaobing ELSEVIER Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells 2021 journal of the European Society for Therapeutic Radiology and Oncology Amsterdam [u.a.] (DE-627)ELV00004122X volume:145 year:2020 pages:178-185 extent:8 https://doi.org/10.1016/j.radonc.2020.01.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA AR 145 2020 178-185 8 |
| language |
English |
| source |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:145 year:2020 pages:178-185 extent:8 |
| sourceStr |
Enthalten in Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells Amsterdam [u.a.] volume:145 year:2020 pages:178-185 extent:8 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Stereotactic body radiotherapy Pulmonary oligometastases Nomogram Oligometastasis Intrathoracic control |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| authorswithroles_txt_mv |
Pasalic, Dario @@aut@@ Lu, Yi @@oth@@ Betancourt-Cuellar, Sonia L. @@oth@@ Taku, Nicolette @@oth@@ Mesko, Shane M. @@oth@@ Bagley, Alexander F. @@oth@@ Chance, William W. @@oth@@ Allen, Pamela K. @@oth@@ Tang, Chad @@oth@@ Antonoff, Mara B. @@oth@@ Balter, Peter A. @@oth@@ Mehran, Reza J. @@oth@@ Welsh, James W. @@oth@@ Liao, Zhongxing @@oth@@ Gomez, Daniel @@oth@@ Erasmus, Jeremy J. @@oth@@ Nguyen, Quynh-Nhu @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00004122X |
| dewey-sort |
3570 |
| id |
ELV050049801 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050049801</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624161606.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2020.01.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050049801</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(20)30022-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pasalic, Dario</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stereotactic body radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pulmonary oligometastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nomogram</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oligometastasis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intrathoracic control</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lu, Yi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Betancourt-Cuellar, Sonia L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taku, Nicolette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mesko, Shane M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bagley, Alexander F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chance, William W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allen, Pamela K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Chad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antonoff, Mara B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balter, Peter A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehran, Reza J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Welsh, James W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liao, Zhongxing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gomez, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Erasmus, Jeremy J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nguyen, Quynh-Nhu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:145</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:178-185</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2020.01.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">145</subfield><subfield code="j">2020</subfield><subfield code="h">178-185</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Pasalic, Dario |
| spellingShingle |
Pasalic, Dario ddc 570 Elsevier Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure |
| authorStr |
Pasalic, Dario |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00004122X |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 540 VZ Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control Elsevier |
| topic |
ddc 570 Elsevier Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control |
| topic_unstemmed |
ddc 570 Elsevier Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control |
| topic_browse |
ddc 570 Elsevier Stereotactic body radiotherapy Elsevier Pulmonary oligometastases Elsevier Nomogram Elsevier Oligometastasis Elsevier Intrathoracic control |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y l yl s l b c slb slbc n t nt s m m sm smm a f b af afb w w c ww wwc p k a pk pka c t ct m b a mb mba p a b pa pab r j m rj rjm j w w jw jww z l zl d g dg j j e jj jje q n n qnn |
| hierarchy_parent_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| hierarchy_parent_id |
ELV00004122X |
| dewey-tens |
570 - Life sciences; biology 540 - Chemistry |
| hierarchy_top_title |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00004122X |
| title |
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure |
| ctrlnum |
(DE-627)ELV050049801 (ELSEVIER)S0167-8140(20)30022-0 |
| title_full |
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure |
| author_sort |
Pasalic, Dario |
| journal |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| journalStr |
Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
178 |
| author_browse |
Pasalic, Dario |
| container_volume |
145 |
| physical |
8 |
| class |
570 540 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Pasalic, Dario |
| doi_str_mv |
10.1016/j.radonc.2020.01.010 |
| dewey-full |
570 540 |
| title_sort |
stereotactic ablative radiation therapy for pulmonary metastases: improving overall survival and identifying subgroups at high risk of local failure |
| title_auth |
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure |
| abstract |
• Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. |
| abstractGer |
• Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. |
| abstract_unstemmed |
• Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure |
| url |
https://doi.org/10.1016/j.radonc.2020.01.010 |
| remote_bool |
true |
| author2 |
Lu, Yi Betancourt-Cuellar, Sonia L. Taku, Nicolette Mesko, Shane M. Bagley, Alexander F. Chance, William W. Allen, Pamela K. Tang, Chad Antonoff, Mara B. Balter, Peter A. Mehran, Reza J. Welsh, James W. Liao, Zhongxing Gomez, Daniel Erasmus, Jeremy J. Nguyen, Quynh-Nhu |
| author2Str |
Lu, Yi Betancourt-Cuellar, Sonia L. Taku, Nicolette Mesko, Shane M. Bagley, Alexander F. Chance, William W. Allen, Pamela K. Tang, Chad Antonoff, Mara B. Balter, Peter A. Mehran, Reza J. Welsh, James W. Liao, Zhongxing Gomez, Daniel Erasmus, Jeremy J. Nguyen, Quynh-Nhu |
| ppnlink |
ELV00004122X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.radonc.2020.01.010 |
| up_date |
2024-07-06T23:15:29.176Z |
| _version_ |
1803873397429501952 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV050049801</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624161606.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">200518s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.radonc.2020.01.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000982.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV050049801</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0167-8140(20)30022-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pasalic, Dario</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Stereotactic ablative radiation therapy for pulmonary metastases: Improving overall survival and identifying subgroups at high risk of local failure</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Retrospective analysis of stereotactic ablative radiation therapy (SABR) for lung metastases. • SABR improved local, intra-thoracic control, and overall survival at a median 24-month follow-up. • Metastases from adrenal, colorectal, sarcoma, or pancreatic tumors were less likely to respond. • Nomogram for local control probability at 24 months. • Irradiating all thoracic metastases improved overall survival and suppressed new lesions.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stereotactic body radiotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pulmonary oligometastases</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nomogram</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Oligometastasis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Intrathoracic control</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lu, Yi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Betancourt-Cuellar, Sonia L.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Taku, Nicolette</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mesko, Shane M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bagley, Alexander F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chance, William W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Allen, Pamela K.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Chad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antonoff, Mara B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Balter, Peter A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mehran, Reza J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Welsh, James W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liao, Zhongxing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gomez, Daniel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Erasmus, Jeremy J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nguyen, Quynh-Nhu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Han, Xiaobing ELSEVIER</subfield><subfield code="t">Identification of proteins related with pemetrexed resistance by iTRAQ and PRM-based comparative proteomic analysis and exploration of IGF2BP2 and FOLR1 functions in non-small cell lung cancer cells</subfield><subfield code="d">2021</subfield><subfield code="d">journal of the European Society for Therapeutic Radiology and Oncology</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00004122X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:145</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:178-185</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.radonc.2020.01.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">145</subfield><subfield code="j">2020</subfield><subfield code="h">178-185</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.400342 |